Whole Genome Sequence-Based Analyses of Drug Resistance Characteristics, Genetic Diversity, and Transmission Dynamics of Drug-Resistant Mycobacterium tuberculosis in Urumqi City
DOI: https://doi.org/10.2147/idr.s454913
2024-03-24
Infection and Drug Resistance
Abstract:Jiandong Yang, 1 Yaoqin Lu, 2 Yanggui Chen, 2 Yida Wang, 1 Kai Wang 3 1 School of Public Health, Xinjiang Medical University, Urumqi, 830017, People's Republic of China; 2 Department of Tuberculosis Control and Prevention, Urumqi Center for Disease Control and Prevention, Urumqi, 830026, People's Republic of China; 3 State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, School of Public Health, Xinjiang Medical University, Urumqi, 830017, People's Republic of China Correspondence: Kai Wang, State Key Laboratory of Pathogenesis, Prevention and Treatment of High Incidence Diseases in Central Asia, School of Public Health, Xinjiang Medical University, Urumqi, 830017, People's Republic of China, Email Objective: This study aims to analyze the drug resistance spectrum, genetic diversity, and transmission dynamics to provide a basis for the prevention and control of drug-resistant (DR) tuberculosis (TB) epidemics. Methods: This retrospective study is based on routine national drug resistance surveillance. The demographic, epidemiological, and clinical information on DR-TB patients from 2016 to 2021 was collected and used for phenotypic drug susceptibility testing and whole-genome sequencing. Results: It was indicated that L2.2.1 was the dominant lineage in Urumqi. The drug resistance spectrum in Urumqi was narrow, which means more drug combinations can be used for clinical treatment. Furthermore, mutations identification of drug-resistance gene katG, rpoB, embA/B, rrs, rpsL, eis, gyrA/B, folC and tryA are important for clinical drug use. However, mutations in cross-resistance genes rrs have limited guidance for clinical selection of KM, CPM and AK. Moreover, there is an increased risk of cluster transmission of DR-TB, and the difference in clustering rate among L2, L3, and L4 was not statistically significant ( χ 2 = 2.6410, p = 0.2670). Conclusion: In the Urumqi, DR-TB has a complex prevalence state, a narrow drug resistance spectrum, and a high clustering rate and burden of drug resistance. To reduce the burden of DR-TB, related research should be strengthened, and the development of prevention, control, and treatment strategies should be accelerated. Keywords: Mycobacterium tuberculosis , resistance, whole genome sequencing, transmission dynamics, Urumqi Tuberculosis (TB) has been a threat to public health for decades and prevailed even during the COVID-19 pandemic. According to the WHO Global Tuberculosis Report 2020, there were approximately 9.96 million new cases, and the population with latent TB infection was approximately 2 billion. 1 In the past four years, the COVID-2019 pandemic had varying impacts on the global TB control system, with access to TB services particularly affected, especially multidrug-resistant TB (MDR-TB) and extensively drug-resistant (DR) TB. 2,3 DR-TB is widely recognized as a challenging and burdensome disease that poses a significant obstacle to TB control. 4 The Global Tuberculosis Report 2022 indicated a substantial increase in the global burden of DR-TB by 2021, with only one-third of these patients receiving treatment, which has a success rate of merely 60%. 5 This alarming trend undermines the WHO's objective of eliminating TB by 2035. Therefore, it is essential to prioritize DR-TB prevention and control in the post-pandemic era. The use of whole genome sequencing (WGS) in genomic research of pathogenic microorganisms has continued to advance. 6 In the field of TB research, the identification and publication of the whole genome sequence of Mycobacterium tuberculosis (MTB) H37Rv in 1998 paved the way for the application of WGS technology. This technology has provided a foundation for investigating the evolutionary patterns of the MTB, understanding their transmission and drug resistance mechanisms, as well as elucidating their virulence evolution and infection mechanisms at the molecular level. 7 Furthermore, as the research on the molecular epidemiology and biology of TB progresses, these techniques have a broad range of applications in investigating TB outbreaks, identifying chains of transmission, determining infections, diagnosing, treating patients, and even conducting routine surveillance. 7 The Xinjiang Uygur Autonomous Region, located in northwestern China, has the highest TB burden in the country. 8 According to the Tuberculosis Epidemiological Survey in China and Xinjiang (the date of survey were 2010 and 2011, respectively), the prevalence of standardized active TB among individuals aged ≥ 15 years a -Abstract Truncated-
pharmacology & pharmacy,infectious diseases